{"id":"W4249126278","doi":"10.1016/j.brachy.2015.02.200","title":"Low-Dose-Rate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavourable Risk Prostate Cancer: The Results of the ASCENDE-RT* Randomized Control Trial","year":2015,"lang":"en","type":"article","venue":"Brachytherapy","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Interior Health; Island Health","funders":"","keywords":"Medicine; Prostate cancer; Brachytherapy; Androgen deprivation therapy; Urology; Clinical endpoint; Randomization; Randomized controlled trial; Prostate; Surgery; Nuclear medicine; Cancer; Internal medicine; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002529427,0.002107101,0.003386125,0.0005280438,0.0004797447,0.001701803,0.001470457,0.002219887,0.00699593],"category_scores_gemma":[0.003933839,0.0006670039,0.004073462,0.0005539049,0.001715732,0.001559673,0.0005706406,0.003351029,0.0008080239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008164844,"about_ca_system_score_gemma":0.0006338276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001272837,"about_ca_topic_score_gemma":0.001678827,"domain_scores_codex":[0.9985355,0.0008848545,0.00009363023,0.0002684438,0.00008707088,0.0001304688],"domain_scores_gemma":[0.9979339,0.0008811434,0.0005498244,0.0002690048,0.00008082206,0.0002854214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986904,0.001408297,0.0007080095,0.0004817985,0.002449037,0.00002188105,0.00002460283,0.0003097777,0.0008958498,0.0001195134,0.0005688649,0.006108326],"study_design_scores_gemma":[0.9530709,0.03513318,0.005255808,0.0000954263,0.004096753,0.0000445941,0.00003806021,0.0007421488,0.0003764381,0.0004257738,0.0006874767,0.00003345357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790418,0.01207806,0.0009781825,0.001178054,0.00113154,0.0008524324,0.001247733,0.0001898459,0.0033025],"genre_scores_gemma":[0.9920977,0.002241056,0.0008189693,0.0008285172,0.0008386385,0.0004681607,0.0009603885,0.00004005803,0.001706454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00699593,"threshold_uncertainty_score":0.02340364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0231220848198861,"score_gpt":0.3059732543734943,"score_spread":0.2828511695536082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}